islet isolation COMES TO THE RESCUE
The primary objective of IsletIsolation for Type 1 and Type 3C diabetes patients is to curtail the daily regimen of insulin therapy & to make this a reality.
“Let’s Pave The Way For Diabetic Free Nations”
INDIA’S FIRST islet Isolation lab
The alarming rise in Diabetes prevalence calls
for an immediate action.
131 Million lives are at stake
The available treatment is presently aided by medications
which have multiple side effects
Seizures
Weight gain
ER
Pancreatitis
Chronic
Hypoglycemia
Uncontrolled
Sweating
Currently in India
Absence of active and functional Islets transplant centers to outweigh insulin usage
Lack of sophisticated equipments and infrastructure
Less maintenance and improper preservation techniques for graft tissue from pancreas
Minimal awareness of this procedure to meet potential donors
How it works
skip to content
Isolation of islets of Langerhan from donor’s pancreas through automated methods.
Clearance of impurities
from the cells.
Reintroduction into Hepatic portal vein in recipient – allotransplantation for type 1 auto-transplantation for Chronic pancreatitis.
Reintroduction into Hepatic portal vein in recipient – allotransplantation for type 1 auto-transplantation for Chronic pancreatitis. Activation of beta cell.
01
Isolation of islets of Langerhan from donor’s pancreas through automated methods
02
Clearance of impurities from the cells
03
Reintroduction into Hepatic portal vein in recipient - allotransplantation for type 1 autotransplantation for Chronic pancreatitis.
04
Activation of beta cell
HOW IT WORKS
01
Isolation of islets of Langerhan from donor’s pancreas through automated methods
02
Clearance of impurities from the cells
03
Reintroduction into Hepatic portal vein in recipient - allotransplantation for type 1 autotransplantation for Chronic pancreatitis. activation of beta cell
04
Reintroduction into Hepatic portal vein in recipient - allotransplantation for type 1 autotransplantation for Chronic pancreatitis. activation of beta cell
Advantages
Cost
effective
Internationally recognized
Lesser
complication
Increased glycemic control
Less
invasive
Stabilize the diabetic economy
Universal Validation
Centers in
asia
asia
0
Centers in
europe
europe
0
Centers in
Oceania
Oceania
0
Centers in south america
0
Encapsulated Human Islet transplantation is in practice in developed countries since 2000.
It showed favorable outcomes after clinical trials with lesser setbacks.
NO. OF TRANSPLANTATION
islet Isolation is backed up
and appreciated by recognised institutions of
India such as
FUTURE
PROJECTIONS
2024
Allocation of resources for microencapsulation of islet cells from donors and Long-term side
effects from immunosuppression of Diabetic patients can be relieved with the Islet transplantation program.
2026
Followed by extensive clinical trials among the population. Ultimately progress into establishment of CGMP program with accessibility.
2022
Establishing the working proof of Islet transplantation with the population.
FUTURE
PROJECTIONS
2022
Establishing the working proof of Islet transplantation with the population.
2024
Allocation of resources for microencapsulation of islet cells from donors and Long term side
effects from immunosuppression of Diabetic patients can be relieved with the Islet transplantation program
2026
Followed by extensive clinical trials among the population. Ultimately progress into establishment of CGMP program with accessibility
Market value
Diabetes in India
has increased from
26 MILLION
77 MILLION
150%
Increase
Estimated
increase by 2045
105%
India has the second highest
number of children with type
1 diabetes.
Age-wise distribution
60+
30 - 58
< 29
Occurrence
The chances of diabetics in urban area is twice that of rural area.
According British medical journal, The 5 Lancet,
Indians spend
1,50,000 Crore
Per annum
CASE STUDY 1
CASE STUDY 2
